U.S. top court says extracted human DNA cannot be patented

WASHINGTON, June 13 Thu Jun 13, 2013 10:34am EDT

WASHINGTON, June 13 (Reuters) - The U.S. Supreme Court on Thursday issued a mixed ruling in a case concerning patents held by Myriad Genetics Inc over the closely watched issue of whether human genes can be patented.

In a unanimous vote, the nine justices reached a compromise by saying synthetically produced genetic material can be patented but that genes extracted from the human body, known as isolated DNA, do not merit the same legal protections.